WASHINGTON, Nov. 08, 2023 (GLOBE NEWSWIRE) — In a significant stride toward ensuring equitable access to cancer treatments, Members of the House of Representatives reintroduced the Cancer Drug Parity Act today. The bill has garnered widespread endorsement from prominent healthcare organizations and patient advocacy groups. The International Myeloma Foundation (IMF),…Read More
Cancer Drug Parity Act Gains Strong Support from Leading Healthcare Organizations
